Table 4.
Time | Statistical parameters | Non-CDI patients | All CDI patients | Patients without rCDI | Patients with 1 rCDI | Patients with 2 rCDIs | Patients with ≥ 3 rCDIs | Patients with ≥ 1 rCDIs |
---|---|---|---|---|---|---|---|---|
6-month mortality | Number of patients at index date | 16,845 | 5,618 | 4,552 | 803 | 185 | 78 | 1,066 |
Number of deaths | 2,832 | 1,460 | 1,172 | 221 | 48 | 19 | 288 | |
Follow-up time in patient-months | 88,691 | 27,241 | 21,914 | 3,946 | 963 | 417 | 5,327 | |
Mortality rate (/100 patient-months) | 3.19 | 5.36 | 5.35 | 5.6 | 4.98 | 4.55 | 5.41 | |
Excess mortality (/100 patient-months)a | Ref. | 2.17 | 2.26 | 2.06 | 1.20 | 0.32 | 1.78 | |
95% CI for excess mortality | 1.87; 2.47 | 1.92; 2.59 | 1.25; 2.87 | -0.38; 2.78 | -2.04; 2.68 | 1.09; 2.46 | ||
12-month mortality | Number of deaths | 3,680 | 1,795 | 1,444 | 257 | 65 | 29 | 351 |
Follow-up time in patient-months | 168,435 | 50,711 | 40,979 | 7,294 | 1,705 | 732 | 9,732 | |
Mortality rate (/100 patient-months) | 2.18 | 3.54 | 3.52 | 3.52 | 3.81 | 3.96 | 3.61 | |
Excess mortality (/100 patient-months)a | Ref. | 1.35 | 1.41 | 1.06 | 1.19 | 1.26 | 1.10 | |
95% CI for excess mortality | 1.18; 1.53 | 1.21; 1.61 | 0.59; 1.54 | 0.16; 2.21 | -0.34; 2.85 | 0.68; 1.52 | ||
24-month mortality | Number of deaths | 4,658 | 2,216 | 1,769 | 330 | 82 | 35 | 447 |
Follow-up time in patient-months | 298,692 | 88,517 | 71,739 | 12,684 | 2,879 | 1,215 | 16,779 | |
Mortality rate (/100 patient-months) | 1.56 | 2.50 | 2.47 | 2.60 | 2.85 | 2.88 | 2.66 | |
Excess mortality (/100 patient-months)a | Ref. | 0.94 | 0.96 | 0.83 | 1.00 | 0.82 | 0.86 | |
95% CI for excess mortality | 0.83; 1.06 | 0.84; 1.09 | 0.52; 1.14 | 0.33; 1.68 | -0.24; 1.87 | 0.59; 1.13 |
CDI Clostridioides difficile infection; rCDI, recurrent CDI infection; CI, confidence interval
aThe reference group to estimate excess mortality in CDI patients, overall and according to the number of rCDI, was constituted by the respective matched non-CDI patients of each group of interest